Đang chuẩn bị liên kết để tải về tài liệu:
A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG Tải xuống

Hepatocellular carcinoma (HCC) remains the most frequent liver cancer, accounting for approximately 90% of primary liver cancers worldwide. The recurrence-free survival (RFS) of HCC patients is a critical factor in devising a personal treatment plan. Thus, it is necessary to accurately forecast the prognosis of HCC patients in clinical practice. |